aTYR PHARMA CEO Sanjay Shukla's 2018 pay falls 36% to $1.4M
aTYR PHARMA reports 2018 executive compensation
By ExecPay News
Published: March 28, 2019
aTYR PHARMA reported fiscal year 2018 executive compensation information on March 28, 2019.
In 2018, four executives at aTYR PHARMA received on average a compensation package of $801K, a 54% decrease compared to previous year.
Average pay of disclosed executives at aTYR PHARMA
Sanjay S. Shukla, Chief Executive Officer, received $1.4M in total, which decreased by 36% compared to 2017. 57% of Shukla's compensation, or $780K, was in option awards. Shukla also received $141K in non-equity incentive plan, $450K in salary, as well as $9.9K in other compensation.
Ashraf Amanullah, Former Senior Vice President, Biologics, Development and Manufacturing, received a compensation package of $772K. 49% of the compensation package, or $377K, was in other compensation.
David J. King, Chief Scientific Officer, earned $717K in 2018, a 31% increase compared to previous year.
Jill M. Broadfoot, Chief Financial Officer, received $334K in 2018.
Related executives
You may also like
Source: SEC filing on March 28, 2019.